跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,517 条关于
“GEP-NET”
全部
19,517
临床试验
12,344
药物
1,166
机构
240
资讯
5,767
11个月前
Sanofi's AlphaMedix Radioligand Therapy Meets All Primary Endpoints in Phase 2 GEP-NET Trial
去年
Grand Pharmaceutical's ITM-11 Phase III Trial Accepted for GEP-NETs in China
6个月前
Lantheus Receives FDA Tentative Approval for First Generic Version of LUTATHERA for Neuroendocrine Tumors
去年
ITM-11 Demonstrates Superior Progression-Free Survival Compared to Everolimus in GEP-NETs
去年
ITM-11 Radiopharmaceutical Achieves Phase III Success in GEP-NETs, Outperforming Everolimus
3天前
FDA Approves Curium's Bexlutry, First Generic Radioligand, Challenging Lutathera's GEP-NET Monopoly
11个月前
XTR008 Achieves Dramatic Progression-Free Survival Benefit in Advanced Gastroenteropancreatic Neuroendocrine Tumors
去年
ITM to Present Phase 3 COMPETE Trial Data at SNMMI 2025 Meeting
11个月前
AlphaMedix Achieves All Primary Endpoints in Phase 2 Trial for Gastroenteropancreatic Neuroendocrine Tumors
11个月前
ITM's Phase 3 COMPETE Trial Dosimetry Data Shows Targeted Tumor Uptake for 177Lu-edotreotide in Neuroendocrine Tumors
第 1 页,共 577 页
上一页
下一页